Coming fresh off an IDE approval by FDA, Beta Bionics is set to integrate Senseonics’ Eversense CGM into the artificial intelligence-powered Bionic Pancreas.
News & Features
With the East Coast's largest medtech event less than a week away, we've highlighted some of the expert-led sessions, networking opportunities, and technologies you won't want to miss during the three-day event at the Javits Center in New York City next week.
Medtronic reaffirmed delaying its surgical robotics platform, which is expected to be a direct competitor to Intuitive Surgical’s da Vinci system.
A University of California, San Francisco program provides the infrastructure for surgeons to innovate.
An industry expert talks about new autoinjector designs that can address the specific wants and needs of individual patients.
Designers of wearable health devices will walk the catwalk at MD&M East to showcase the products that are enabling new capabilities in mobile healthcare, with a focus on prevention, screening, and disease management.
Genetesis is developing a noninvasive and accurate chest pain triage, and has closed an oversubscribed round of $7.5M in series A financing.
Bluetooth technology may be the gold standard in connected health, but what about the pitfalls? One diabetes management company argues that cell-enabled technology is the way to go.
Philips is set to pick up EPD Solutions, a company that specializes in image-guided procedures for cardiac arrhythmias, for about $292 million upfront, in a transaction set to be completed in July.
FDA said a total of 12 patients have died in the past two years after receiving either the Orbera or the ReShape balloon-based systems to treat obesity.
ThinkGenetic’s co-founder and CEO is set to moderate panel at MD&M East and discuss how artificial intelligence is growing in healthcare and helping to redefine the medtech space.
The Class I recall includes 204,017 HeartWare devices, but the likelihood of the problem causing a serious adverse event in a patient is very low.